← Back to Search
Nanoparticulate Systems For The Delivery Of Antisense Oligonucleotides.
G. Lambert, E. Fattal, P. Couvreur
Published 2001 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Antisense oligonucleotides are molecules that are able to inhibit gene expression being therefore potentially active for the treatment of viral infections or cancer. However, because of their poor stability in biological medium and their weak intracellular penetration, colloidal drugs carriers such as nanoparticles were developed for the delivery of oligonucleotides (ODN). ODN associated to nanoparticles were shown to be protected against degradation and to penetrate more easily into different types of cells. As a consequence, nanoparticles were shown to improve the efficiency of ODNs for the inhibition of the proliferation of cells expressing the point mutated Ha-ras gene. In vivo, polyalkylcyanoacrylate (PACA) nanoparticles were able to efficiently distribute the ODNs to the liver whereas the alginate nanosponges could concentrate the ODNs in the lungs. Finally, ODN loaded to PACA nanoparticles were able to improve in mice, the treatment of RAS cells expressing the point mutated Ha-ras gene.
This paper references
Preparation of injectable controlled-release microcapsules by a solvent-evaporation process
T. R. Tice (1985)
Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis.
E. Fattal (1991)
Emulsifier-free emulsion copolymerization of styrene with two different amino-containing cationic monomers. I. Kinetic studies
F. Ganachaud (1997)
Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier.
I. Aynié (1996)
Preparation and Characterization of Novel Poly(methylidene Malonate 2.1.2.)-Made Nanoparticles
F. Lescure (2004)
Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells.
G. Lambert (1998)
Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules.
J. Rollot (1986)
Degradation of poly (isobutyl cyanoacrylate) nanoparticles.
V. Lenaerts (1984)
Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice.
J. De Keyser (1991)
In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells.
V. Lenaerts (1984)
Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition.
R. Roberts (1992)
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size
E. Allémann (1992)
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
A. Gabizon (1988)
Cationic Polystyrene Nanoparticles: Preparation and Characterization of a Model Drug Carrier System for Antisense Oligonucleotides
Poly(ethylene glycol)-coated nanospheres: potential carriers for intravenous drug administration.
R. Gref (1997)
Interfacial Polymerization, A Useful Method for the Preparation of Polymethylcyanoacrylate Nanoparticles
H. Krause (1986)
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.
I. A. Bakker-Woudenberg (1993)
The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.
Y. Castier (1998)
Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.
T. Verrecchia (1993)
Triple helix-specific ligands.
J. Mergny (1992)
Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading
B. Seijo (1990)
Characterization of oligonucleotide transport into living cells.
S. Loke (1989)
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?
L. Yakubov (1989)
Effect of charge nature on the adsorption of single-stranded DNA fragments onto latex particles
A. Elaissari (1998)
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.
M. Peracchia (1997)
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
D. Papahadjopoulos (1991)
Pharmacokinetics and Biodistribution of Oligonucleotide Adsorbed onto Poly(isobutylcyanoacrylate) Nanoparticles After Intravenous Administration in Mice
Y. Nakada (2004)
Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides.
E. Fattal (1998)
Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
D. Bazile (1995)
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?
C. Stein (1993)
Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides.
H. Zobel (1997)
The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process
F. Koosha (1989)
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol).
M. Peracchia (1997)
Adsorption and desorption studies of polyadenylic acid onto positively charged latex particles
A. Elaïssari (1995)
Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.
G. Schwab (1994)
Adsorption of Single-Stranded DNA Fragments onto Cationic Aminated Latex Particles
F. Ganachaud (1997)
Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation.
P. Beal (1991)
Targeting of drugs
G. Gregoriadis (1977)
Antisense effects of cholesterol-oligodeoxynucleotide conjugates associated with poly(alkylcyanoacrylate) nanoparticles.
G. Godard (1995)
Encapsulation of oligonucleotides in stealth Me.PEG-PLA50 nanoparticles by complexation with structured oligopeptides.
Carole Emile (1996)
CpG DNA: a novel immunomodulator.
A. Krieg (1999)
Adsorption of oligonucleotides onto negatively and positively charged latex particles
A. Elaissari (1994)
Antisense oligonucleotides: is the glass half full or half empty?
C. Bennett (1998)
Anti‐inflammatory activity of cationic lipids
M. Filion (1997)
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures
A. Ellington (1992)
Emulsifier-free emulsion copolymerization of styrene with two different amino-containing monomers: II. Surface and colloidal characterization
F. Sauzedde (1997)
Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides.
I. Aynié (1999)
Progress toward oligonucleotide therapeutics: pharmacodynamic properties
S. Crooke (1993)
Nanoparticles as Carriers for Antisense Oligonucleotides
O. Balland (1996)
CpG motifs in bacterial DNA trigger direct B-cell activation
Arthur M. Krieg (1995)
New method for the preparation of cyanoacrylic nanoparticles with improved colloidal properties.
V. Lenaerts (1989)
Aqueous nanodispersions prepared by a salting-out process
H. Ibrahim (1992)
Preparation and characterization of cationic polystyrene latex particles of different aminated surface charges
F. Ganachaud (1995)
Recognition and cleavage of hairpin structures in nucleic acids by oligodeoxynucleotides.
J. François (1994)
Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey.
W. M. Galbraith (1994)
The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
T. Burgess (1995)
An approach for new anticancer drugs: oncogene-targeted antisense DNA.
G. Schwab (1994)
Development of poly (dialkyl methylidenemalonate) nanoparticles as drug carriers
T.K.M. T.K.M. Mbela (1993)
Antisense and antigene properties of peptide nucleic acids.
J. Hanvey (1992)
Molecular Weights of Free and Drug-Loaded Nanoparticles
Luc Vansnick (2004)
This paper is referenced by
Computational genes: a tool for molecular diagnosis and therapy of aberrant mutational phenotype
I. Martínez-Pérez (2007)
Nanotechnology‐Enabled Delivery Systems for Food Functionalization and Fortification
Rashmi Tiwari (2012)
UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE FARMÁCIA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS Nanoemulsões catiônicas como sistemas de liberação de oligonucleotídeos: Formulação e caracterização físico-química
P. Alegre (2005)
Poly(Alkyl Cyanoacrylate) Nanoparticles for Delivery of Anti-Cancer Drugs
R. R. Murthy (2006)
Liposomes incorporating a Plasmodium amino acid sequence target heparan sulfate binding sites in liver.
R. Robertson (2008)
PLGA-based nanoparticles: A new paradigm in biomedical applications
Shweta R. Sharma (2016)
Synthesis and colon-specific drug delivery of a poly(acrylic acid-co-acrylamide)/MBA nanosized hydrogel
Debajyoti Ray (2008)
Requirements for delivery of active antisense oligonucleotides into cells with lipid carriers.
I. Jääskeläinen (2004)
Title DNA-based nano-sized systems for pharmaceutical and biomedical applications
Sakulrat Rattanakiat (2017)
From molecular biology to nanotechnology and nanomedicine.
K. Bogunia-Kubik (2002)
Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.
Zengshuan Ma (2008)
Degradable polyelectrolyte capsules filled with oligonucleotide sequences.
A. Zelikin (2006)
Stability Assessment and Formulation Characterization
Albert Hee Lum Chow (2010)
Drug Delivery to The Brain Using Polymeric Nanoparticles: A Review
Bhatt Neha (2013)
Oligonucleotides as radiopharmaceuticals.
B. Tavitian (2005)
Metal- and Polymer-Based Nanoparticles for Advanced Therapeutic and Diagnostic System Applications
Nicole Bassous (2020)
Dry Powder Aerosol Nanocomposite Microparticles for the Treatment of Pulmonary Diseases
Zimeng Wang (2016)
Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
R. C. Nagarwal (2009)
Increasing the yield of iron-dextran nanoparticles by ultrasonic treatment
X. Gao (2019)
Preparation and Physicochemical Characterization of Eudragit ® RL100 Nanosuspension with potential for Ocular Delivery of Sulfacetamide
Bivash Mandal (2010)
NANOPARTICLES: A PROMISING DRUG DELIVERY APPROACH
R. Kadian (2018)
Nanoparticles for Drug Delivery
A. Lowman (2006)
Nanoemulsions: the properties, methods of preparation and promising applications
M. Koroleva (2012)
DIFFERENT TECHNIQUES FOR PREPARATION OF POLYMERIC NANOPARTICLES-A
H. K. Yadav (2012)
Optimizing the delivery systems of chimeric RNA.DNA oligonucleotides.
Li Liang (2002)
A NANOSCALE POLYNUCLEOTIDE-NEUTRAL LIPOSOME SELF-ASSEMBLIES FORMULATED FOR THERAPEUTIC GENE DELIVERY
C. Científico (2004)
Chapter Thirty-Five – Gene Delivery into Cells and Tissues
Prokop Ales (2007)
Biodegradable alginate microparticles developed by electrohydrodynamic spraying techniques for oral delivery of protein
Tittaya Suksamran (2009)
New experimental therapeutic approaches for degenerative diseases of the retina
J. Tombran-tink (2003)
Effects of anticoagulant and time of plasma separation on measurement of homocysteine.
N. Duarte (2002)
Nanoparticle-modified polyelectrolyte capsules
P. Gil (2008)
An in vitro study of peptide-loaded alginate nanospheres for antagonizing the inhibitory effect of Nogo-A protein on axonal growth.
Peng Zhai (2015)See more